Rh2 also diminished metastatic activities of pancreatic (Bxpc-3 at a dose of 45 μM) and lung (A549 at a dose of 60 and 100 μM) cancer cells via inhibition of MMP-2 and MMP-9 [97,98]. The gene discussed is MMP2; the disease is cancer.